Prolia 60 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F1AC7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,882
Award facts
- Contract value 100% obligated
- $13,882.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,882.03 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of January 20, 2026, and was awarded on January 16, 2026, with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the prime vehicle for delivering comprehensive pharmaceutical and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor and healthcare solutions provider within the federal medical procurement system, particularly for military and veteran healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to competitively supply diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Prolia—a bone density treatment medication—reflects the company's ongoing role in fulfilling essential pharmaceutical commodities for federal healthcare agencies and military treatment facilities.
Quick answers
Who was awarded contract SPE2DR26F1AC7?
SPE2DR26F1AC7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F1AC7 worth?
The government has obligated $13,882 on SPE2DR26F1AC7.
Is contract SPE2DR26F1AC7 an order under another contract?
Yes. SPE2DR26F1AC7 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AC7 competed?
The extent of competition for SPE2DR26F1AC7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award